methscopolamine bromide

methscopolamine bromide

[meth′skōpō′ləmēn]
an anticholinergic/antispasmodic.
indications It is prescribed in the treatment of hypermotility of the GI tract and as an adjunct in treatment of peptic ulcer.
contraindications Narrow-angle glaucoma, asthma, obstruction of the genitourinary or GI tract, severe ulcerative colitis, or known hypersensitivity to this drug prohibits its use.
adverse effects Blurred vision, central nervous system effects, tachycardia, dry mouth, decreased sweating, or hypersensitivity reactions may occur.
Mentioned in ?
References in periodicals archive ?
the go-ahead to market methscopolamine bromide tablets, a generic version of Pamine, the peptic ulcer treatment marketed by the Kenwood Therapeutics division of Bradley Pharmaceuticals Inc.
Featured products on the Boca Pharmacal web site include antipyrine and benzocaine otic solution; levetiracetam 250-mg, 500-mg and 750-mg tablets; methscopolamine bromide 2-mg tablets USP; methscopolamine bromide 5-mg tablets USP; and carbinoxamine maleate 4-mg liquid and tablets.